President Donald Trump says he's “pretty much” made his decision on whom to endorse in Texas’ heated Republican Senate primary, but he still refuses to name his pick publicly. On Friday in Corpus Christi, Texas, he praised the three — Ken Paxton, John Cornyn and Wesley Hunt — in the same speech. He also repeated his main campaign themes on the economy, energy, and security. Democrats have responded by arguing that costs keep rising for Texas families. The GOP primary, set for March 3, has turned personal, as party leaders push Trump to back Cornyn. Paxton faces lingering controversy, while Hunt sells himself as a loyal Trump ally.
President Donald Trump has said the U.S. was sending a hospital ship to Greenland because people there are not getting care, but the claim faces pushback. He said in a Truth Social post Saturday that the ship was already on the way, though at the time he posted, the two U.S. ships appeared to be docking in Alabama. Publicly available ship tracking data shows that on Tuesday one of the ships, the USNS Mercy, went out to sea. It's not clear from the public data where the ship is headed, and Pentagon officials didn't comment when asked about its destination. The leaders of Greenland and Denmark have defended their health care system in response to Trump's allegations.
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower prices in the U.S. or face new limits on what the government will pay. In doing so, he incorrectly placed the blame for the high prices on foreign nations. The AP examined the facts.
Some cancer patients are hitting coverage limits on a cheap anti-nausea pill that can ward off waves of vomiting after treatment. Doctors say restrictions on the number of tablets can hurt care. Pharmacy benefit managers say their restrictions guard against overuse. In between sits patients. They may have to ration pills or opt for less-effective help. The conflict offers a glimpse at how relatively simple acts of care can grow complex in the fragmented U.S. health care system.
The Biden administration says Medicare recipients will save about $1.5 billion dollars on medications to for diabetes, heart disease, types of arthritis and other ailments under new prices negotiated with drug companies that will take effect in 2026. The savings range from 79% for Januvia, a drug to treat diabetes to 38% for Imbruvica, which is used to treat blood cancers. That is the medication’s cost before any discounts or rebates are applied, but not what the price people actually pay when filling their prescriptions.